Published February 1992 | Version v1
Journal article

Production of 6-[18F]fluoro-L-DOPA and its metabolism in vivo -a critical review

  • 1. Universite Libre de Bruxelles (Belgium). Hopital Erasme
  • 2. Liege Univ. (Belgium). Centre de Recherches du Cyclotron
  • 3. California Univ., Los Angeles, CA (United States). Lab. of Nuclear Medicine and Radiation Biology
  • 4. Hammersmith Hospital, London (United Kingdom). M.R.C. Cyclotron Unit
  • 5. Turku Medical Cyclotron Project (Finland)
  • 6. Aabo Akademi Accelerator Lab., Turku (Finland)
  • 7. Max-Planck-Institut fuer Neurologische Forschung, Koeln (Germany)

Description

This report critically appraises methods for the synthesis of 6-[18F ]fluoro-L-3,4-dihydroxyphenylalanine (6-FDOPA) that are based on labelling by non-regioselective electrophilic fluorination, regioselective fluorodemetalation or nucleophilic substitution. Recommendations for the standardization of labelling procedures, the optimization of radiochemical yield and the assurance of product quality and safety are given. Studies of the metabolism of 6-FDOPA in vivo are also reviewed to emphasize the importance of the biochemical component of the development of this tracer for positron emission tomography (PET). (Author)

Additional details

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
19
Journal Issue
2
Series
Nucl. Med. Biol.
Journal Page Range
149-158
ISSN
0883-2897
CODEN
NMBIE